lncRNA MIR100HG-derived miR-100 and miR-125b mediate cetuximab resistance via Wnt/β-catenin signaling
Yuanyuan Lu(National Clinical Research Center for Digestive Diseases), Robert J. Coffey(Vanderbilt University), Christine H. Chung(Moffitt Cancer Center), Jeffrey L. Franklin(San Francisco VA Medical Center), Jan‐Henning Klusmann(Goethe University Frankfurt), Scott A. Hinger(Vanderbilt University Medical Center), Ramona Graves‐Deal(Vanderbilt University Medical Center), James G. Patton(Vanderbilt University), Xiaodi Zhao(National Clinical Research Center for Digestive Diseases), Cunxi Li(Xiamen University), Stephan Emmrich(University of Rochester), Kenyi Saito‐Diaz(University of Georgia), Huaying Hu(Xiamen University), Ethan Lee(Johns Hopkins University), Bhuminder Singh(Vanderbilt University Medical Center), Jing Wang(Tianjin Medical University General Hospital), Qi Liu(Vanderbilt University Medical Center), Zheng Cao(Taihe Hospital), Daiming Fan(National Clinical Research Center for Digestive Diseases), Tianying Wei(Xiamen University), Timothy J. Yeatman(University of South Florida), Mingli Yang(Zunyi Medical University)
Cited by 460
Related Papers
Proteogenomic characterization of human colon and rectal cancer
|Nature|2014|1.6k
Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA
|Annals of Oncology|2020|1.5k
Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-Galactose
|New England Journal of Medicine|2008|1.5k
The structure of the G protein heterotrimer Giα1β1γ2
|Cell|1995|1.1k